IP Library › Granted Patent US 7,794,437
Granted Patent B2
US 7,794,437 · App. 10/543,083 · Granted Sep 14, 2010

Reservoirs with subretinal cannula for subretinal drug delivery

Assignee: Doheny Retina Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,794,437
App. No.
10/543,083
Granted
Sep 14, 2010
Kind
B2
Abstract

Featured are devices and methods for administering a therapeutic medium to the posterior segment of an eye including instilling or disposing the therapeutic medium sub-retinally. Such instillation is accomplished by providing a reservoir containing a therapeutic medium to which is fluidly coupled a cannula and inserting a portion of the cannula sub-retinally, whereby the therapeutic medium within the reservoir is coupled to and dispersed subretinally via the cannula.

Claims (39)

1. A subretinal delivery device comprising:

a reservoir;

a cannula extending from the reservoir, the cannula having a length and being configured such that it extends from the reservoir through the vitreous and through the retina with a distal end terminating in a subretinal space when the reservoir is disposed exterior the eye on the sclera or when the reservoir is disposed within the eye;

a securing mechanism near the distal end of the cannula configured to secure a distal portion of the cannula to the retina; and

wherein the cannula is configured so that an agent in the reservoir is released from the reservoir through the cannula to the eye subretinally.

2. The device of claim 1 , wherein the reservoir is an external reservoir.

3. The device of claim 2 , wherein the external reservoir is fixed on the pars plana.

4. The device of claim 1 , wherein the reservoir is a pars plana reservoir.

5. The device of claim 4 , wherein the pars plana reservoir is introduced through a sclerotomy and implanted within the eye.

6. The device of claim 1 , wherein the reservoir is an intraocular lens reservoir.

7. The device of claim 6 , wherein the intraocular lens reservoir is incorporated to the periphery of an intraocular lens, and the lens is placed either to the anterior or posterior chamber.

8. The device of claim 7 , wherein the reservoir is a ring-like.

9. The device of claim 1 , wherein the reservoir is an epiretinal reservoir.

10. The device of claim 9 , wherein the epiretinal reservoir is fixed on the retina via a tack through an aperture in the reservoir.

11. The device of claim 9 , wherein the cannula emerges from the reservoir, travels inside the vitreous and inserts into the retina.

12. The device of claim 1 , wherein the reservoir is fabricated of a polymer.

13. The device of claim 1 , wherein the cannula end is disposed subretinally so as to release the agent through the subretinal space, physiologically via the retinal pigment epithelium pump.

14. The device of claim 1 , wherein the reservoir is configured and arranged so it can be reloaded with agent.

15. The device of claim 14 , wherein the reservoir is configured and arranged so such reloading can be accomplished by piercing the reservoir with an injection device and injecting the agent therein without the formation of a leak.

16. The device of claim 15 , wherein the injection device is a syringe.

17. The device of claim 1 , wherein the reservoir can withstand multiple injections without leakage.

18. The device of claim 1 wherein the securing mechanism is a tab near the distal end of the cannula that is securable to the retina.

19. The device of claim 18 wherein the tab is secured to the retina using a tack.

20. A method for the treatment of ocular conditions comprising the steps of:

implanting an agent delivery device comprising a reservoir and a cannula extending from the reservoir into the eye such that the reservoir is disposed exterior the eye on the sclera or within the eye, with the cannula extending from the reservoir through the retina into a subretinal space; and

allowing the agent in the reservoir to be delivered to the eye via the cannula subretinally.

21. The method of claim 20 , further comprising the step of:

reloading the reservoir with agent.

22. The method of claim 21 , wherein said reloading includes piercing the reservoir with an injection device and injecting the agent.

23. The device of claim 22 , wherein the injection device is a syringe.

24. The method of claim 20 wherein the agent is controllably delivered to the eye.

25. The method of claim 24 wherein the agent is controllably delivered based at least in part on the cannula design.

26. The method of claim 24 or 25 wherein the agent is controllably delivered at least in part physiologically via the retinal pigment epithelium pump.

27. A subretinal delivery device comprising:

a reservoir;

a cannula extending from the reservoir;

the cannula having a length and being configured to extend from the reservoir through the vitreous and through the retina into a subretinal space when the reservoir is disposed exterior the eye on the sclera or when the reservoir is disposed within the eye;

the cannula having a pointed distal end for insertion through the retina, the distal end and at least a distal portion of the cannula having a cross-sectional size that allows for disposal and retainment within the subretinal space between the retina and choroid of the eye; and

wherein an agent in the reservoir is released through the cannula to the eye subretinally.

Continuity (2)
Provisional Application 6044232300 · Jan 24, 2003
Related Publication 20060200097A1 · Sep 7, 2006